Journey Medical (DERM) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$0.09.
- Journey Medical's EPS (Weighted Average and Diluted) rose 2500.0% to -$0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 6276.6%. This contributed to the annual value of -$0.72 for FY2024, which is 24195.73% down from last year.
- Latest data reveals that Journey Medical reported EPS (Weighted Average and Diluted) of -$0.09 as of Q3 2025, which was up 2500.0% from -$0.16 recorded in Q2 2025.
- In the past 5 years, Journey Medical's EPS (Weighted Average and Diluted) ranged from a high of $0.8 in Q3 2023 and a low of -$1.89 during Q4 2021
- For the 5-year period, Journey Medical's EPS (Weighted Average and Diluted) averaged around -$0.4, with its median value being -$0.18 (2025).
- As far as peak fluctuations go, Journey Medical's EPS (Weighted Average and Diluted) crashed by 92173.91% in 2021, and later surged by 24035.09% in 2023.
- Over the past 5 years, Journey Medical's EPS (Weighted Average and Diluted) (Quarter) stood at -$1.89 in 2021, then skyrocketed by 68.25% to -$0.6 in 2022, then soared by 80.0% to -$0.12 in 2023, then skyrocketed by 164.52% to $0.08 in 2024, then plummeted by 216.23% to -$0.09 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.09 in Q3 2025, compared to -$0.16 in Q2 2025 and -$0.18 in Q1 2025.